Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection.

BACKGROUND Few data on the effect of human papillomavirus (HPV) infection on human immunodeficiency virus (HIV) acquisition are available. METHODS HIV-seronegative, sexually active, 18-24-year-old Kenyan men participating in a randomized trial of male circumcision provided exfoliated penile cells from 2 anatomical sites (glans/coronal sulcus and shaft) at baseline. The GP5+/6+ polymerase chain reaction assay ascertained a wide range of HPV DNA types at the baseline visit. The risk of HIV infection was estimated using Kaplan-Meier methods and hazard ratios from proportional hazards models. RESULTS Of 2168 uncircumcised men with baseline HPV data, 1089 (50%) were positive for HPV DNA. The cumulative incidence of HIV infection by 42 months was 5.8% (95% confidence interval [CI], 3.6%-7.9%) among men with HPV-positive glans/coronal sulcus specimens, versus 3.7% [95% CI, 1.8%-5.6%] among men with HPV-negative glans/coronal sulcus specimens (P = .01). Controlling for subsequent circumcision status, baseline herpes simplex virus type 2 serostatus, and sexual and sociodemographic risk factors, the hazard ratio for HIV infection among men with HPV-positive glans/coronal sulcus specimens was 1.8 (95% CI, 1.1-2.9), compared with men with HPV-negative glans/coronal sulcus specimens. CONCLUSION The results suggest an independent increased risk of HIV seroconversion among HPV-positive men. If this finding is confirmed in other studies, HPV prevention could be another tool for HIV prevention.

[1]  W. D. Ray.  4. Modelling Survival Data in Medical Research , 1995 .

[2]  A. Puren,et al.  Association of Oncogenic and Nononcogenic Human Papillomavirus With HIV Incidence , 2010, Journal of acquired immune deficiency syndromes.

[3]  J. Kahn,et al.  HPV vaccination for the prevention of cervical intraepithelial neoplasia. , 2009, The New England journal of medicine.

[4]  J. M. van der Hulst,et al.  Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. , 2002, Cancer research.

[5]  S. Pambuccian,et al.  Glycerol monolaurate prevents mucosal SIV transmission , 2009, Nature.

[6]  Daron G Ferris,et al.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.

[7]  G. Kvåle.  Preventing HIV-1: lessons from Mwanza and Rakai , 1999, The Lancet.

[8]  M. Stanley,et al.  Immunological events in regressing genital warts. , 1994, American journal of clinical pathology.

[9]  R. Hayes,et al.  Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials , 2000, The Lancet.

[10]  M. Hudgens,et al.  Human Papillomavirus Detection by Penile Site in Young Men From Kenya , 2007, Sexually transmitted diseases.

[11]  Ross D. Cranston,et al.  Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men , 2009, AIDS.

[12]  C. Meijer,et al.  HPV DNA detection and typing in cervical scrapes. , 2005, Methods in molecular medicine.

[13]  C. Meijer,et al.  Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. , 2002, Journal of the American Academy of Dermatology.

[14]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[15]  M. Stanley.  Immunobiology of HPV and HPV vaccines. , 2008, Gynecologic oncology.

[16]  P. Snijders,et al.  Flat penile lesions: The infectious “invisible” link in the transmission of human papillomavirus , 2006, International journal of cancer.

[17]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[18]  C. Wheeler,et al.  Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.

[19]  Stephen Moses,et al.  Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya , 2005, BJU international.

[20]  J. Nyengaard,et al.  Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer , 2007, British Journal of Cancer.

[21]  Jose Jeronimo,et al.  Human papillomavirus and cervical cancer , 2007, The Lancet.

[22]  B. Thiers.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial , 2008 .